Literature DB >> 16195816

Refinement of the DFNA41 locus and candidate genes analysis.

Denise Yan1, Xiao Mei Ouyang1, Xiaofeng Zhu2, Li Lin Du1, Zheng Yi Chen3, Xue Zhong Liu4.   

Abstract

We previously mapped the 41rst gene locus (DFNA41) for autosomal dominant hearing loss on chromosome 12q24-qter in a large multi-generational Chinese family. We determined that DFNA41 is located in a 15 cM region, proximal to the marker D12S1609. A maximum two point LOD score of 6.56 at theta = 0.0 was obtained with marker D12S343. In the current study, screening of eight candidate genes within the DFNA41 interval did not reveal the mutation causing deafness in this family. Eight highly informative single nucleotide polymorphisms (SNPs) in the region of D12S343 were selected for linkage and association study. Because the pedigree studied here is a large family with many founders, we applied the transmission/disequilibrium (TDT) test. To account for the dependence of small families and the relatively small sample size, simulations were performed to obtain P-values. For three nearby SNPs spanning a 7 kb interval, we found significant evidence of linkage and association. The highest Z score of linkage and association of 3.6 (P < or = 0.0001) was obtained for SNP rs1566667. Haplotype analysis revealed that affected individuals were heterozygous for one core SNP (rs1027560-rs1027557-rs1566667-rs1463865-rs2078105) CAGTC haplotype, confirming location and autosomal dominant inheritance of the DFNA41 locus. Examination of pairwise LD calculation identified a major haplotype block defined by the four most centromeric SNPs. This study represents a significant refinement of the DFNA41 locus and should facilitate positional cloning of the disease gene.

Entities:  

Mesh:

Year:  2005        PMID: 16195816     DOI: 10.1007/s10038-005-0286-0

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  20 in total

1.  Correcting for a potential bias in the pedigree disequilibrium test.

Authors:  E R Martin; M P Bass; N L Kaplan
Journal:  Am J Hum Genet       Date:  2001-04       Impact factor: 11.025

2.  Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex.

Authors:  A J Jeffreys; L Kauppi; R Neumann
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

3.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

4.  The Interaction of Selection and Linkage. I. General Considerations; Heterotic Models.

Authors:  R C Lewontin
Journal:  Genetics       Date:  1964-01       Impact factor: 4.562

Review 5.  Genetic epidemiology of hearing impairment.

Authors:  N E Morton
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

6.  Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics.

Authors:  E Sobel; K Lange
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

7.  Mutations in the myosin VIIA gene cause non-syndromic recessive deafness.

Authors:  X Z Liu; J Walsh; P Mburu; J Kendrick-Jones; M J Cope; K P Steel; S D Brown
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

8.  Cochlear pathology in presbycusis.

Authors:  H F Schuknecht; M R Gacek
Journal:  Ann Otol Rhinol Laryngol       Date:  1993-01       Impact factor: 1.547

9.  Linkage-disequilibrium mapping narrows the Fukuyama-type congenital muscular dystrophy (FCMD) candidate region to <100 kb.

Authors:  T Toda; M Miyake; K Kobayashi; K Mizuno; K Saito; M Osawa; Y Nakamura; I Kanazawa; Y Nakagome; K Tokunaga; Y Nakahori
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

10.  Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland.

Authors:  J Hästbacka; A de la Chapelle; I Kaitila; P Sistonen; A Weaver; E Lander
Journal:  Nat Genet       Date:  1992-11       Impact factor: 38.330

View more
  5 in total

1.  Hearing loss caused by a P2RX2 mutation identified in a MELAS family with a coexisting mitochondrial 3243AG mutation.

Authors:  Hideaki Moteki; Hela Azaiez; Kevin T Booth; Mitsuru Hattori; Ai Sato; Yoshihiko Sato; Mitsuo Motobayashi; Christina M Sloan; Diana L Kolbe; A Eliot Shearer; Richard J H Smith; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-18       Impact factor: 1.547

2.  Mutation of the ATP-gated P2X(2) receptor leads to progressive hearing loss and increased susceptibility to noise.

Authors:  Denise Yan; Yan Zhu; Tom Walsh; Dinghua Xie; Huijun Yuan; Asli Sirmaci; Taro Fujikawa; Ann Chi Yan Wong; Tze L Loh; Lilin Du; M'hamed Grati; Srdjan M Vlajkovic; Susan Blanton; Allen F Ryan; Zheng-Yi Chen; Peter R Thorne; Bechara Kachar; Mustafa Tekin; Hong-Bo Zhao; Gary D Housley; Mary-Claire King; Xue Z Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

Review 3.  The genetic bases for non-syndromic hearing loss among Chinese.

Authors:  Xiao Mei Ouyang; Denise Yan; Hui Jun Yuan; Dai Pu; Li Lin Du; Don Yi Han; Xue Zhong Liu
Journal:  J Hum Genet       Date:  2009-02-06       Impact factor: 3.172

4.  Specific expression of Kcna10, Pxn and Odf2 in the organ of Corti.

Authors:  Francesca A Carlisle; Karen P Steel; Morag A Lewis
Journal:  Gene Expr Patterns       Date:  2012-03-16       Impact factor: 1.224

5.  Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus.

Authors:  Sonia Garritano; Federica Gemignani; Catherine Voegele; Tú Nguyen-Dumont; Florence Le Calvez-Kelm; Deepika De Silva; Fabienne Lesueur; Stefano Landi; Sean V Tavtigian
Journal:  BMC Genet       Date:  2009-02-17       Impact factor: 2.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.